Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Pyxis Oncology Inc.’s current trading price is -51.73% away from its 52-week high, while its distance from the 52-week low is 203.64%. The stock’s price range during this period has varied between $1.10 and $6.92. The company, active in the Healthcare sector, saw a trading volume of around 0.93 million for the day, considerably lower average daily volume of 3.9 million observed over the last three months.
Currently, the stock price of Pyxis Oncology Inc. (PYXS) is $3.34. In the most recent trading session, the stock underwent a significant upswing, peaking at $3.54 after opening at $3.53. The stock touched a low of $3.12 before closing at $3.73.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
The stock market performance of Pyxis Oncology Inc. has been very steady. Over the last year, the company’s stock hit its highest at $6.92 on 03/30/23, while the lowest price during the same time frame was $1.10, recorded on 12/15/22.
How Financial Performance Impacts Market Capitalization
Pyxis Oncology Inc. (PYXS) has experienced a quarterly rise of 41.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 127.79M and boasts a workforce of 73 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.48, with a change in price of +2.04. Similarly, Pyxis Oncology Inc. recorded 2,463,592 in trading volume during the last 100 days, posting a change of +156.92%.
How PYXS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for PYXS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
PYXS Stock Stochastic Average
As of today, the raw stochastic average of Pyxis Oncology Inc. over the last 50 days is at 28.97%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 51.15%. Further, the company’s Stochastic %K and %D values for the last 20 days were 68.19% and 74.81%, respectively.
PYXS Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 149.25%. However, over the past six months, we’ve seen a weaker performance of 136.88%. The price of PYXS fallen by 10.60% over the last 30 days. And in the last five days, it has fallen by -9.97%.
